Works by Heijns, Joan B.

Results: 15

Development of a Clinical Prediction Model for 1-Year Mortality in Patients With Advanced Cancer.

Published in:

JAMA Network Open, 2022, v. 5, n. 11, p. e2244350, doi. 10.1001/jamanetworkopen.2022.44350

By:

Owusuaa, Catherine;
van der Padt-Pruijsten, Annemieke;
Drooger, Jan C.;
Heijns, Joan B.;
Dietvorst, Anne-Marie;
Janssens-van Vliet, Ellen C. J.;
Nieboer, Daan;
Aerts, Joachim G. J. V.;
van der Heide, Agnes;
van der Rijt, Carin C. D.

Publication type:

Article

Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 841, doi. 10.1007/s00280-007-0671-9

By:

Heijns, Joan B.;
van der Burg, Maria E. L.;
van Gelder, Teun;
Fieren, Marien W. J. A.;
de Bruijn, Peter;
van der Gaast, Ate;
Loos, Walter J.

Publication type:

Article

Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survival.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00563-w

By:

Verschoor, Noortje;
de Weerd, Vanja;
Van, Mai N.;
Kraan, Jaco;
Smid, Marcel;
Heijns, Joan B.;
Drooger, Jan C.;
Zuetenhorst, Johanna M.;
van der Padt-Pruijsten, Annemieke;
Jager, Agnes;
Sleijfer, Stefan;
Martens, John W. M.;
Wilting, Saskia M.

Publication type:

Article

Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer: Results From the SONABRE Registry.

Published in:

Clinical Breast Cancer, 2024, v. 24, n. 2, p. 103, doi. 10.1016/j.clbc.2023.10.009

By:

Ibragimova, Khava I. E.;
Geurts, Sandra M. E.;
Laczkó, Dávid;
Meegdes, Marissa;
Erdkamp, Frans;
Heijns, Joan B.;
Tol, Jolien;
Vriens, Birgit E. P. J.;
Aaldering, Kirsten N. A.;
Dercksen, Marcus W.;
Pepels, Manon J. A. E.;
Peters, Natascha A. J. B.;
van de Winkel, Linda M. H.;
van de Wouw, Agnes J.;
de Fallois, Aude;
van Kats, Maartje A. C. E.;
Tjan-Heijnen, Vivianne C. G.

Publication type:

Article

A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy-free approach in HER2-positive metastatic breast cancer: The HAT study (BOOG 2008-2003), a Dutch Breast Cancer Research Group trial.

Published in:

2016

By:

Drooger, Jan C.;
van Tinteren, Harm;
de Groot, Steffen M.;
ten Tije, Albert J.;
de Graaf, Hiltje;
Portielje, Johanneke E. A.;
Jager, Agnes;
Honkoop, Aafke;
Linn, Sabine C.;
Kroep, Judith R.;
Erdkamp, Frans L. G.;
Hamberg, Paul;
Imholz, Alex L. T.;
van Rossum‐Schornagel, Quirine C.;
Heijns, Joan B.;
van Leeuwen‐Stok, A. Elise;
Sleijfer, Stefan

Publication type:

journal article

Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01).

Published in:

2016

By:

de Groot, Stefanie;
Charehbili, Ayoub;
van Laarhoven, Hanneke W. M.;
Mooyaart, Antien L.;
Dekker-Ensink, N. Geeske;
van de Ven, Saskia;
Janssen, Laura G. M.;
Swen, Jesse J.;
Smit, Vincent T. H. B. M.;
Heijns, Joan B.;
Kessels, Lonneke W.;
van der Straaten, Tahar;
Böhringer, Stefan;
Gelderblom, Hans;
van der Hoeven, Jacobus J. M.;
Guchelaar, Henk-Jan;
Pijl, Hanno;
Kroep, Judith R.;
Dutch Breast Cancer Research Group

Publication type:

journal article

Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry.

Published in:

Breast Cancer Research & Treatment, 2024, v. 205, n. 2, p. 287, doi. 10.1007/s10549-023-07235-0

By:

Geurts, Sandra M. E.;
Ibragimova, Khava I. E.;
Ding, Nan;
Meegdes, Marissa;
Erdkamp, Frans;
Heijns, Joan B.;
Tol, Jolien;
Vriens, Birgit E. P. J.;
Dercksen, Marcus W.;
Aaldering, Kirsten N. A.;
Pepels, Manon J. A. E.;
van de Winkel, Linda;
Peters, Natascha A. J. B.;
van de Wouw, Agnes J.;
Maaskant, Sabrina A. J. G.;
Teeuwen-Dedroog, Nathalie J. A.;
van Nijnatten, Thiemo J. A.;
de Boer, Maaike;
Tjan-Heijnen, Vivianne C. G.

Publication type:

Article

The prognostic impact of BMI in patients with HR+/HER2− advanced breast cancer: a study of the SONABRE registry.

Published in:

Breast Cancer Research & Treatment, 2024, v. 203, n. 2, p. 339, doi. 10.1007/s10549-023-07108-6

By:

Lammers, Senna W. M.;
Thurisch, Hannah;
Vriens, Ingeborg J. H.;
Meegdes, Marissa;
Engelen, Sanne M. E.;
Erdkamp, Frans L. G.;
Dercksen, M. Wouter;
Vriens, Birgit E. P. J.;
Aaldering, Kirsten N. A.;
Pepels, Manon J. A. E.;
van de Winkel, Linda M. H.;
Peters, Natascha A. J. B.;
Tol, Jolien;
Heijns, Joan B.;
van de Wouw, Agnes J.;
Teeuwen, Nathalie J. A.;
Geurts, Sandra M. E.;
Tjan-Heijnen, Vivianne C. G.

Publication type:

Article

Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry.

Published in:

Breast Cancer Research & Treatment, 2023, v. 198, n. 2, p. 239, doi. 10.1007/s10549-022-06832-9

By:

Ibragimova, Khava I. E.;
Geurts, Sandra M. E.;
Meegdes, Marissa;
Erdkamp, Frans;
Heijns, Joan B.;
Tol, Jolien;
Vriens, Birgit E. P. J.;
Dercksen, Marcus W.;
Aaldering, Kirsten N. A.;
Pepels, Manon J. A. E.;
van de Winkel, Linda;
Peters, Natascha A. J. B.;
Teeuwen-Dedroog, Nathalie J. A.;
Vriens, Ingeborg J. H.;
Tjan-Heijnen, Vivianne C. G.

Publication type:

Article

The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry.

Published in:

Breast Cancer Research & Treatment, 2022, v. 192, n. 2, p. 331, doi. 10.1007/s10549-021-06472-5

By:

Meegdes, Marissa;
Ibragimova, Khava I. E.;
Lobbezoo, Dorien J. A.;
Vriens, Ingeborg J. H.;
Kooreman, Loes F. S.;
Erdkamp, Frans L. G.;
Dercksen, M. Wouter;
Vriens, Birgit E. P. J.;
Aaldering, Kirsten N. A.;
Pepels, Manon J. A. E.;
van de Winkel, Linda M. H.;
Tol, Jolien;
Heijns, Joan B.;
van de Wouw, Agnes J.;
Peters, Natascha A. J. B.;
Hochstenbach-Waelen, Ananda;
Smidt, Marjolein L.;
Geurts, Sandra M. E.;
Tjan-Heijnen, Vivianne C. G.

Publication type:

Article

Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry.

Published in:

Breast Cancer Research & Treatment, 2021, v. 188, n. 2, p. 571, doi. 10.1007/s10549-021-06178-8

By:

Ibragimova, Khava I. E.;
Geurts, Sandra M. E.;
Croes, Sander;
Erdkamp, Frans;
Heijns, Joan B.;
Tol, Jolien;
Vriens, Birgit E. P. J.;
Aaldering, Kirsten N. A.;
Dercksen, Marcus W.;
Pepels, Manon J. A. E.;
Peters, Natascha A. J. B.;
van de Winkel, Linda;
Tilli, Dominique J. P.;
Vriens, Ingeborg J. H.;
de Boer, Maaike;
Tjan-Heijnen, Vivianne C. G.

Publication type:

Article

Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013–14) trial.

Published in:

Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 741, doi. 10.1007/s10549-020-05991-x

By:

Lugtenberg, Rieneke T.;
de Groot, Stefanie;
Kaptein, Ad A.;
Fischer, Maarten J.;
Kranenbarg, Elma Meershoek-Klein;
Carpentier, Marjolijn Duijm-de;
Cohen, Danielle;
de Graaf, Hiltje;
Heijns, Joan B.;
Portielje, Johanneke E. A.;
van de Wouw, Agnes J.;
Imholz, Alex L. T.;
Kessels, Lonneke W.;
Vrijaldenhoven, Suzan;
Baars, Arnold;
Fiocco, Marta;
van der Hoeven, Jacobus J. M.;
Gelderblom, Hans;
Longo, Valter D.;
Pijl, Hanno

Publication type:

Article

Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study.

Published in:

Breast Cancer Research & Treatment, 2021, v. 185, n. 2, p. 441, doi. 10.1007/s10549-020-05966-y

By:

Simons, Janine M.;
Jacobs, Julien G.;
Roijers, Joost P.;
Beek, Maarten A.;
Boonman-de Winter, Leandra J. M.;
Rijken, Arjen M.;
Gobardhan, Paul D.;
Wijsman, Jan H.;
Tetteroo, Eric;
Heijns, Joan B.;
Yick, C. Y.;
Luiten, Ernest J. T.

Publication type:

Article

Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I-IIIB breast cancer receiving chemotherapy.

Published in:

Breast Cancer Research & Treatment, 2019, v. 173, n. 2, p. 475, doi. 10.1007/s10549-018-5014-5

By:

van den Berg, Maaike M. G. A.;
Kok, Dieuwertje E.;
Posthuma, Liesbeth;
Kamps, Lisette;
Kelfkens, Celine S.;
Buist, Nicole;
Geenen, Maud;
Haringhuizen, Annebeth;
Heijns, Joan B.;
van Lieshout, Rianne H. M. A.;
Los, Maartje;
Sommeijer, Dirkje W.;
Timmer-Bonte, Johanna N. H.;
de Kruif, Anja Th. C. M.;
van Laarhoven, Hanneke W. M.;
Kampman, Ellen;
Winkels, Renate M.

Publication type:

Article

Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01).

Published in:

2019

By:

de Groot, Stefanie;
Pijl, Hanno;
Charehbili, Ayoub;
van de Ven, Saskia;
Smit, Vincent T. H. B. M.;
Meershoek-Klein Kranenbarg, Elma;
Heijns, Joan B.;
van Warmerdam, Laurence J. C.;
Kessels, Lonneke W.;
Dercksen, M. Wouter;
Pepels, Manon J. A. E.;
van Laarhoven, Hanneke W. M.;
Vriens, Birgit E. P. J.;
Putter, Hein;
Fiocco, Marta;
Liefers, Gerrit-Jan;
van der Hoeven, Jacobus J. M.;
Nortier, Johan W. R.;
Kroep, Judith R.;
Dutch Breast Cancer Research Group

Publication type:

journal article